Since VEGFA is frequently overexpressed in OVCA (Yu et al, 2013) and VEGF/VEGFR‐targeted therapies have significant activity in this cancer (Eskander & Tewari, 2014), we investigated whether VEGFA drives ovarian CSC expansion and sought to identify targetable pathways mediating these effects. The gene discussed is VEGFA; the disease is cancer.